LongCYTKJun 2026
Cytokinetics, Incorporated
Polaris added Cytokinetics following FDA approval of Myqorzo for hypertrophic cardiomyopathy. The fund believes Myqorzo compares favorably with Bristol Myers Squibb's Camzyos…
CYTK
Which hedge funds are long CYTK?
2 published ideas on Cytokinetics, Incorporated across 2 funds — 2 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Cytokinetics, Incorporated: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Funds with a position view
Long theses
LongCYTKJun 2026
Cytokinetics, Incorporated
Polaris added Cytokinetics after FDA approval of Myqorzo for hypertrophic cardiomyopathy. The manager views Myqorzo as superior to Bristol Myers Squibb's Camzyos because it…